Comparison of health-related quality of life in children and adolescents with monosymptomatic nocturnal enuresis under therapy versus allergic bronchial asthma, diabetes mellitus type I, and juvenile idiopathic arthritis – a KINDL-R-based study

Patients under therapy for MNE without achieving dryness showed no significant differences in overall HRQoL or individual dimensions compared to the reference groups, but a significantly lower HRQoL in the chronic-generic module in children and parents (group 7-13 years) and in adolescents (14-17 years of age). This result is consistent with reported limitations in self-esteem and HRQoL before therapy and supports the need and importance of adequate therapy for MNE.